Great Point Partners as of Sept. 30, 2014
Portfolio Holdings for Great Point Partners
Great Point Partners holds 36 positions in its portfolio as reported in the September 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Hyperion Therapeutics | 8.6 | $20M | 794k | 25.22 | |
Neurocrine Biosciences (NBIX) | 7.8 | $18M | 1.2M | 15.67 | |
Infinity Pharmaceuticals (INFIQ) | 6.3 | $15M | 1.1M | 13.42 | |
Alimera Sciences | 6.1 | $14M | 2.6M | 5.42 | |
Ophthotech | 5.0 | $12M | 300k | 38.93 | |
Endologix | 4.4 | $10M | 973k | 10.60 | |
Derma Sciences | 4.2 | $9.7M | 1.2M | 8.33 | |
Aradigm | 4.2 | $9.7M | 1.0M | 9.59 | |
Ambit Bioscience | 4.0 | $9.2M | 600k | 15.40 | |
Ocera Therapeutics | 3.9 | $9.1M | 1.9M | 4.90 | |
Orthofix International Nv Com Stk | 3.5 | $8.2M | 265k | 30.96 | |
Alcobra | 3.5 | $8.1M | 523k | 15.47 | |
Aurinia Pharmaceuticals (AUPH) | 3.4 | $7.9M | 2.5M | 3.20 | |
Exelixis (EXEL) | 3.4 | $7.8M | 5.1M | 1.53 | |
Oncothyreon | 3.2 | $7.5M | 3.9M | 1.92 | |
Pain Therapeutics | 3.0 | $7.1M | 1.8M | 3.91 | |
Aastrom Biosciences | 2.7 | $6.2M | 2.2M | 2.85 | |
Emergent BioSolutions (EBS) | 2.6 | $6.2M | 290k | 21.31 | |
Veracyte (VCYT) | 2.5 | $5.9M | 607k | 9.75 | |
HeartWare International | 2.3 | $5.4M | 70k | 77.63 | |
OncoGenex Pharmaceuticals | 2.1 | $4.8M | 1.8M | 2.67 | |
Sophiris Bio | 2.0 | $4.6M | 1.6M | 2.93 | |
Tenax Therapeutics | 1.9 | $4.4M | 1.1M | 3.93 | |
Vical Incorporated | 1.5 | $3.4M | 3.0M | 1.12 | |
Cutera (CUTR) | 1.4 | $3.2M | 315k | 10.10 | |
Sunesis Pharmaceuticals | 1.2 | $2.9M | 400k | 7.14 | |
Anthera Pharmaceutcls | 1.2 | $2.7M | 1.4M | 1.92 | |
Chemocentryx | 0.9 | $2.2M | 484k | 4.50 | |
Wafergen Bio-systems | 0.8 | $1.8M | 422k | 4.35 | |
Onconova Therapeutics | 0.6 | $1.5M | 346k | 4.30 | |
Mei Pharma | 0.5 | $1.1M | 158k | 6.90 | |
Amarin Corporation (AMRN) | 0.4 | $1.0M | 924k | 1.09 | |
Streamline Health Solutions (STRM) | 0.3 | $702k | 152k | 4.63 | |
Thoratec Corporation | 0.3 | $596k | 22k | 26.73 | |
Cara Therapeutics (CARA) | 0.2 | $397k | 47k | 8.39 | |
Zafgen | 0.1 | $331k | 17k | 19.64 |